Last updated on February 2018

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression

Brief description of study

The study will evaluate the efficacy and safety of ITI-007 adjunctive to lithium or valproate in a randomized, double-blind, parallel-group, placebo-controlled, multi-center study in patients diagnosed with Bipolar I or Bipolar II disorder having a major depressive episode.

Clinical Study Identifier: NCT02600507

Contact Investigators or Research Sites near you

Start Over

Kimberly Vanover, Ph.D.

Clinical Site
Pico Rivera, CA United States
  Connect »

Kimberly Vanover, Ph.D.

Clinical Site
Cerritos, CA United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.